Montreal Cognitive Assessment: Normative Data for Cognitively Healthy Swedish 80- to 94-Year-Olds.
Cognitive aging
healthy volunteers
neuropsychological tests
regression analyses
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2022
2022
Historique:
pubmed:
19
4
2022
medline:
9
6
2022
entrez:
18
4
2022
Statut:
ppublish
Résumé
The Montreal Cognitive Assessment (MoCA) is sensitive to cognitive impairment; however, it is also sensitive to demographic and socio-cultural factors. This necessitates reliable sub-population norms, but these are often lacking for older adults. To present demographically adjusted regression-based MoCA norms for cognitively healthy Swedish older adults. A pseudo-random sample of community-dwelling 80- to 94-year-olds, stratified by age and gender, was invited to the study. Initial telephone interviews and medical records searches (n = 218) were conducted to screen for cognitive impairment. N = 181 eligible participants were administered a protocol including the Swedish version of the MoCA and assessments of global cognition (Mini-Mental State Examination, MMSE) and depression (Patient Health Questionnaire-9, PHQ-9). Individuals scoring in the range of possible cognitive impairment on the MMSE or more than mild depression on the PHQ-9 were excluded (n = 23); three discontinued the test-session. Norms were derived from the remaining n = 158. They were evenly distributed by gender, on average 85 years old, and with a mean education of 11 years. MoCA scores were independently influenced by age and education, together explaining 17.2% of the total variance. Higher age and lower education were associated with lower performance and 46% performed below the original cut-off (< 26/30). The negative impact of increasing age on MoCA performance continues linearly into the nineties in normal aging. Demographic factors should be considered when interpreting MoCA performance and a tool for computing demographically corrected standard scores is provided.
Sections du résumé
BACKGROUND
The Montreal Cognitive Assessment (MoCA) is sensitive to cognitive impairment; however, it is also sensitive to demographic and socio-cultural factors. This necessitates reliable sub-population norms, but these are often lacking for older adults.
OBJECTIVE
To present demographically adjusted regression-based MoCA norms for cognitively healthy Swedish older adults.
METHODS
A pseudo-random sample of community-dwelling 80- to 94-year-olds, stratified by age and gender, was invited to the study. Initial telephone interviews and medical records searches (n = 218) were conducted to screen for cognitive impairment. N = 181 eligible participants were administered a protocol including the Swedish version of the MoCA and assessments of global cognition (Mini-Mental State Examination, MMSE) and depression (Patient Health Questionnaire-9, PHQ-9). Individuals scoring in the range of possible cognitive impairment on the MMSE or more than mild depression on the PHQ-9 were excluded (n = 23); three discontinued the test-session.
RESULTS
Norms were derived from the remaining n = 158. They were evenly distributed by gender, on average 85 years old, and with a mean education of 11 years. MoCA scores were independently influenced by age and education, together explaining 17.2% of the total variance. Higher age and lower education were associated with lower performance and 46% performed below the original cut-off (< 26/30).
CONCLUSION
The negative impact of increasing age on MoCA performance continues linearly into the nineties in normal aging. Demographic factors should be considered when interpreting MoCA performance and a tool for computing demographically corrected standard scores is provided.
Identifiants
pubmed: 35431248
pii: JAD215629
doi: 10.3233/JAD-215629
pmc: PMC9198733
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1335-1344Références
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Am J Geriatr Psychiatry. 2018 Dec;26(12):1258-1267
pubmed: 30314940
Int J Geriatr Psychiatry. 2018 Feb;33(2):379-388
pubmed: 28731508
Assessment. 2006 Mar;13(1):62-79
pubmed: 16443719
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(6):755-61
pubmed: 25942388
Ann Intern Med. 1987 Oct;107(4):481-5
pubmed: 3631786
J Alzheimers Dis. 2017;59(3):893-901
pubmed: 28697562
Cochrane Database Syst Rev. 2015 Oct 29;(10):CD010775
pubmed: 26513331
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(4):413-37
pubmed: 25325767
Int J Geriatr Psychiatry. 2009 Feb;24(2):197-201
pubmed: 18850670
Br J Clin Psychol. 2006 Sep;45(Pt 3):393-402
pubmed: 17147104
Arq Neuropsiquiatr. 2019 Nov;77(11):775-781
pubmed: 31826133
Clin Neuropsychol. 2021 Sep 1;:1-16
pubmed: 34470584
Neurol Sci. 2015 Apr;36(4):585-91
pubmed: 25380622
Appl Neuropsychol Adult. 2017 Jan-Feb;24(1):23-29
pubmed: 27144665
J Gerontol. 1982 May;37(3):323-9
pubmed: 7069156
J Clin Exp Neuropsychol. 2011 Nov;33(9):989-96
pubmed: 22082082
J Am Geriatr Soc. 2019 Mar;67(3):534-538
pubmed: 30536796
Neurology. 2011 Sep 27;77(13):1272-5
pubmed: 21917776
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Nat Rev Neurol. 2014 Nov;10(11):634-42
pubmed: 25266297
Neuroepidemiology. 2013;40(1):23-9
pubmed: 23075757
Arch Clin Neuropsychol. 2016 Nov 22;31(7):819-826
pubmed: 27625048
Clin Neuropsychol. 2017 Jan-Dec;31(sup1):1-19
pubmed: 28276861
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Cogn Behav Neurol. 2013 Mar;26(1):1-5
pubmed: 23538566
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2021 Jun 13;:1-20
pubmed: 34121606
Fam Med Community Health. 2020 Feb 16;8(1):e000262
pubmed: 32148735
Int J Geriatr Psychiatry. 2017 Oct;32(10):1085-1093
pubmed: 27593974
Psychiatr Pol. 2016 Oct 31;50(5):1039-1052
pubmed: 27992895
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Geriatr Psychiatry Neurol. 2011 Dec;24(4):184-90
pubmed: 22228824
Alzheimers Dement (Amst). 2016 Jun 29;4:43-6
pubmed: 27489879
J Alzheimers Dis. 2018;64(2):643-655
pubmed: 29945351
Arch Clin Neuropsychol. 2016 May;31(3):246-53
pubmed: 26891720
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Neurocase. 2012;18(4):336-51
pubmed: 22044211
Arch Clin Neuropsychol. 2010 Mar;25(2):126-38
pubmed: 20118110
Aging Clin Exp Res. 2018 Aug;30(8):993-998
pubmed: 29188578